CD4+CD28null cells are an independent predictor of mortality in patients with heart failure

Atherosclerosis

Volumn 230, Issue 2, 2013, Pages 414-416

  Koller, Lorenz ^a   Richter, Bernhard ^a   Goliasch, Georg ^a   Blum, Steffen ^a   Korpak, Magdalena ^a   Zorn, Gerlinde ^a   Brekalo, Mira ^a   Maurer, Gerald ^a   Wojta, Johann ^a   Pacher, Richard ^a   Hülsmann, Martin ^a   Niessner, Alexander ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CD4+CD28null cells; Heart failure; Immune system; Survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CD28 ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NULL CELL; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION;

CD4(+)CD28(NULL) CELLS; HEART FAILURE; IMMUNE SYSTEM; SURVIVAL;

AGED; ANTIGENS, CD28; BODY MASS INDEX; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HUMANS; IMMUNE SYSTEM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84884525726     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.08.008     Document Type: Article

References (10)

1. Liuzzo G., Biasucci L.M., Trotta G., et al. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. Journal of the American College of Cardiology 2007, 50:1450-1458.
2. Schmidt D., Goronzy J.J., Weyand C.M. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. Journal of Clinical Investigation 1996, 97:2027-2037.
3. Weyand C.M., Brandes J.C., Schmidt D., et al. Functional properties of CD4+ CD28- T cells in the aging immune system. Mechanisms of Ageing and Development 1998, 102:131-147.
4. Liuzzo G., Goronzy J.J., Yang H., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000, 101:2883-2888.
5. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal 2012, 33:1787-1847.
6. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000, 102:3060-3067.
7. Bryl E., Vallejo A.N., Weyand C.M., et al. Down-regulation of CD28 expression by TNF-alpha. Journal of Immunology 2001, 167:3231-3238.
8. Wang Y., Chen L., Hagiwara N., et al. Regulation of heat shock protein 60 and 72 expression in the failing heart. Journal of Molecular and Cellular Cardiology 2010, 48:360-366.
9. Vallejo A.N., Weyand C.M., Goronzy J.J. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends in Molecular Medicine 2004, 10:119-124.
10. Nakajima T., Schulte S., Warrington K.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002, 105:570-575.